Sabrena Noria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sabrena Noria has a total of 297 co-authors. Here are the top co-authors by number of shared publications:
- Bradley J. Needleman
Center for Minimally Invasive Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
27 shared publications Bradley Needleman
Division of General and GI Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, USA
9 shared publicationsAnahita Jalilvand
Division of General Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, USA
8 shared publicationsAndrew Suzo
6 shared publications- Keeley J. Pratt
Department of Human Sciences, The Ohio State University, Columbus, Ohio, USA
6 shared publications Dean J. Mikami
Ohio State University (OSU) - Department of Surgery
5 shared publications
Latest Publications
- 22 June 2026
- Published by Springer Nature
- p. 345-356
Management of Marginal Ulcers After Roux-En-Y Gastric Bypass
- 22 June 2026
- Published by Springer Nature
- p. 345-356
Management of Marginal Ulcers After Roux-En-Y Gastric Bypass
- Open Access
- 26 December 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Bidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c
Therapies for type 2 diabetes primarily target hyperglycemia; however, complications are also triggered by advanced glycation end products (AGEs). We hypot
- 26 December 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessBidirectional regulation of liver sinusoidal clearance by amino acid nanofibers and IGFBP4 complex: effects on HbA1c
Therapies for type 2 diabetes primarily target hyperglycemia; however, complications are also triggered by advanced glycation end products (AGEs). We hypot
- Open Access
- 26 November 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (3) , 309-316
Diagnosis and treatment options for chronic abdominal pain after Roux-en-Y gastric bypass
- 26 November 2025
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 22 (3) , 309-316
Open AccessDiagnosis and treatment options for chronic abdominal pain after Roux-en-Y gastric bypass
- Open Access
Human Differentiated Adipocytes as Surrogate Mature Adipocytes for Adipocyte-Derived Extracellular Vesicle Analysis
Obesity is a growing global health concern, contributing to diseases such as cancer, autoimmune disorders, and neurodegenerative conditions. Adipose tissue dysfunction, characterized by abnormal adipokine secretion and chronic inflammation, plays a key role in these conditions. Adipose-derived extracellular vesicles (ADEVs) have emerged as critical mediators in obesity-related diseases. However, the study of mature adipocyte-derived EVs (mAdipo-EVs) is limited due to the short lifespan of mature adipocytes in culture, low EV yields, and the low abundance of these EV subpopulations in the circulation. Additionally, most studies rely on rodent models, which have differences in adipose tissue biology compared to humans. To overcome these challenges, we developed a standardized approach for differentiating human preadipocytes (preAdipos) into mature differentiated adipocytes (difAdipos), which produce high-yield, human adipocyte EVs (Adipo-EVs). Using visceral adipose tissue from bariatric surgical patients, we isolated the stromal vascular fraction (SVF) and differentiated preAdipos into difAdipos. Brightfield microscopy revealed that difAdipos exhibited morphological characteristics comparable to mature adipocytes (mAdipos) directly isolated from visceral adipose tissue, confirming their structural similarity. Additionally, qPCR analysis demonstrated decreased preadipocyte markers and increased mature adipocyte markers, further validating successful differentiation. Functionally, difAdipos exhibited lipolytic activity comparable to mAdipos, supporting their functional resemblance to native adipocytes. We then isolated preAdipo-EVs and difAdipo-EVs using tangential flow filtration and characterized them using bulk and single EV analysis. DifAdipo-EVs displayed classical EV and adipocyte-specific markers, with significant differences in biomarker expression compared to preAdipo-EVs. These findings demonstrate that difAdipos serve as a reliable surrogate for mature adipocytes, offering a consistent and scalable source of adipocyte-derived EVs for studying obesity and its associated disorders.
Open AccessHuman Differentiated Adipocytes as Surrogate Mature Adipocytes for Adipocyte-Derived Extracellular Vesicle Analysis
Obesity is a growing global health concern, contributing to diseases such as cancer, autoimmune disorders, and neurodegenerative conditions. Adipose tissue dysfunction, characterized by abnormal adipokine secretion and chronic inflammation, plays a key role in these conditions. Adipose-derived extracellular vesicles (ADEVs) have emerged as critical mediators in obesity-related diseases. However, the study of mature adipocyte-derived EVs (mAdipo-EVs) is limited due to the short lifespan of mature adipocytes in culture, low EV yields, and the low abundance of these EV subpopulations in the circulation. Additionally, most studies rely on rodent models, which have differences in adipose tissue biology compared to humans. To overcome these challenges, we developed a standardized approach for differentiating human preadipocytes (preAdipos) into mature differentiated adipocytes (difAdipos), which produce high-yield, human adipocyte EVs (Adipo-EVs). Using visceral adipose tissue from bariatric surgical patients, we isolated the stromal vascular fraction (SVF) and differentiated preAdipos into difAdipos. Brightfield microscopy revealed that difAdipos exhibited morphological characteristics comparable to mature adipocytes (mAdipos) directly isolated from visceral adipose tissue, confirming their structural similarity. Additionally, qPCR analysis demonstrated decreased preadipocyte markers and increased mature adipocyte markers, further validating successful differentiation. Functionally, difAdipos exhibited lipolytic activity comparable to mAdipos, supporting their functional resemblance to native adipocytes. We then isolated preAdipo-EVs and difAdipo-EVs using tangential flow filtration and characterized them using bulk and single EV analysis. DifAdipo-EVs displayed classical EV and adipocyte-specific markers, with significant differences in biomarker expression compared to preAdipo-EVs. These findings demonstrate that difAdipos serve as a reliable surrogate for mature adipocytes, offering a consistent and scalable source of adipocyte-derived EVs for studying obesity and its associated disorders.
- 9 December 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (4) , 362-371
Impact of same-day sleeve gastrectomy surgery on postoperative emergency department visits: analysis from the Michigan Bariatric Surgery Collaborative
- 9 December 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (4) , 362-371
Impact of same-day sleeve gastrectomy surgery on postoperative emergency department visits: analysis from the Michigan Bariatric Surgery Collaborative
- 13 November 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (2) , 1234-1242
The impact of social determinants of health (SDOH) on completing bariatric surgery at a single academic institution
Background Underutilization of bariatric surgery is multifactorial. This study aimed to understand the association of SDOH on not achieving surgery. Methods 1081 applications for primary MBS from January-December 2021 were stratified into those that completed surgery (COM; n = 415), in progress > 1-year (IP; n = 107), dropped out (DO; n = 379), and never started (NS; n = 180). Using the American-Community-Survey results (2015–2020) and patient zip-codes, population differences in 4-domains of SDOH (demographic/social/housing/economic) were examined between COM versus the other groups. Additionally, using institutional MBSAQIP and EMR data, patient-specific differences in comorbidities were evaluated for COM versus IP/DO. Univariate analysis using Kruskal–Wallis, chi-squared/Fisher’s exact tests were used for continuous and/or categorical variables. For patient-level analysis multinomial logistic regression was used to determine predictors of not achieving surgery. Hypothesis testing was conducted at an overall 5 percent type-I error rate (alpha = 0.05) and Bonferroni’s method was used to adjust for multiple comparisons. Results Compared to COM, IP-patients resided in zip-codes characterized by fewer married people (43% vs 46%; p = 0.019), lower education levels (49% vs 43%; p = 0.048), more households where rent was > 50% of household income (10% vs 8%, p = 0.002), and households below the poverty line (17.6% vs 14.5%, p = 0.017). At the patient-level, IP were more likely to be male (27.9% vs 14.9%; p = 0.014), publicly insured (44.9% vs 28.4%; p = 0.004), Black (35.5% vs 22.2%; p = 0.006), an active smoker (8.9% vs 2.2%; p = 0.018), have a higher BMI (49.6 vs 47.6; p = 0.01), and coronary intervention (5.8% vs 1.7%, p = 0.034). Comparison of COM vs DO was similar for both phases. Multinomial multivariable logistic regression demonstrated higher BMI (OR = 1.03,[CI]:1.01–1.05, p = 0.001), males (OR = 1.9,[CI]:1.09–3.32, p = 0.024), smoking (OR = 4.58,[CI]:1.74–12.02, p = 0.002), and Medicaid (OR = 2.16,[CI]:1.33–3.49, p = 0.002) independently predicted not achieving surgery. Conclusion Patient-level data demonstrated social not clinical factors predicted surgery completion. Given zip-codes characterizing the IP/DO groups had a greater prevalence of social risk, more attention needs to be directed patient-level social risks.
- 13 November 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (2) , 1234-1242
The impact of social determinants of health (SDOH) on completing bariatric surgery at a single academic institution
Background Underutilization of bariatric surgery is multifactorial. This study aimed to understand the association of SDOH on not achieving surgery. Methods 1081 applications for primary MBS from January-December 2021 were stratified into those that completed surgery (COM; n = 415), in progress > 1-year (IP; n = 107), dropped out (DO; n = 379), and never started (NS; n = 180). Using the American-Community-Survey results (2015–2020) and patient zip-codes, population differences in 4-domains of SDOH (demographic/social/housing/economic) were examined between COM versus the other groups. Additionally, using institutional MBSAQIP and EMR data, patient-specific differences in comorbidities were evaluated for COM versus IP/DO. Univariate analysis using Kruskal–Wallis, chi-squared/Fisher’s exact tests were used for continuous and/or categorical variables. For patient-level analysis multinomial logistic regression was used to determine predictors of not achieving surgery. Hypothesis testing was conducted at an overall 5 percent type-I error rate (alpha = 0.05) and Bonferroni’s method was used to adjust for multiple comparisons. Results Compared to COM, IP-patients resided in zip-codes characterized by fewer married people (43% vs 46%; p = 0.019), lower education levels (49% vs 43%; p = 0.048), more households where rent was > 50% of household income (10% vs 8%, p = 0.002), and households below the poverty line (17.6% vs 14.5%, p = 0.017). At the patient-level, IP were more likely to be male (27.9% vs 14.9%; p = 0.014), publicly insured (44.9% vs 28.4%; p = 0.004), Black (35.5% vs 22.2%; p = 0.006), an active smoker (8.9% vs 2.2%; p = 0.018), have a higher BMI (49.6 vs 47.6; p = 0.01), and coronary intervention (5.8% vs 1.7%, p = 0.034). Comparison of COM vs DO was similar for both phases. Multinomial multivariable logistic regression demonstrated higher BMI (OR = 1.03,[CI]:1.01–1.05, p = 0.001), males (OR = 1.9,[CI]:1.09–3.32, p = 0.024), smoking (OR = 4.58,[CI]:1.74–12.02, p = 0.002), and Medicaid (OR = 2.16,[CI]:1.33–3.49, p = 0.002) independently predicted not achieving surgery. Conclusion Patient-level data demonstrated social not clinical factors predicted surgery completion. Given zip-codes characterizing the IP/DO groups had a greater prevalence of social risk, more attention needs to be directed patient-level social risks.
- 1 November 2024
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 18 (1) , 70-78
Breastfeeding initiation according to the severity of Class 3 obesity
Background: Class 3 obesity is composed of morbid (BMI 40–49 kg/m 2 ) and extreme (BMI ≥ 50 kg/m 2 ) subgroups. Adverse perinatal outcomes have been associated with obesity; however, data on breastfeeding (BF) initiation for women in either group remains limited. Objective: To compare BF initiation rates (exclusive or partial BF) and related comorbidities of 890 women with morbid and 890 with extreme obesity matched by race, parity, and year of delivery. Methods: Retrospective cohort study of women who delivered singletons at ≥ 34 weeks gestation (2013–2021). Those who had bariatric surgery or infants with major malformations were excluded. Results: Both groups were similar in: primiparity (38%), age (29y), white race (58%), African American (36%), current (10 vs 12%) and former (25 vs 27%) smokers, gestational hypertension (15 vs 16%), polycystic ovary syndrome (5 vs 7%), gastroesophageal reflux disease (10 vs 10%), and anemia (17 vs 17%). Women in the extreme group had a higher prevalence of gestational (17 vs 12%) and pregestational diabetes (12 vs 6%), chronic hypertension (41 vs 17%), severe preeclampsia (18 vs 12%), obstructive sleep apnea (12 vs 3%), asthma (22 vs 16%), and cesarean deliveries (62 vs 44%). Intention to BF (64 vs 71%), exclusive BF (23 vs 34%), and BF initiation (57 vs 64%) rates were lower in the extreme obesity group at discharge. Conclusion: Higher frequency of comorbidities in the extreme obesity group highlights the need for antenatal, intrapartum, and postpartum targeted interventions if the benefits of BF to mothers and infants are to be realized.
- 1 November 2024
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 18 (1) , 70-78
Breastfeeding initiation according to the severity of Class 3 obesity
Background: Class 3 obesity is composed of morbid (BMI 40–49 kg/m 2 ) and extreme (BMI ≥ 50 kg/m 2 ) subgroups. Adverse perinatal outcomes have been associated with obesity; however, data on breastfeeding (BF) initiation for women in either group remains limited. Objective: To compare BF initiation rates (exclusive or partial BF) and related comorbidities of 890 women with morbid and 890 with extreme obesity matched by race, parity, and year of delivery. Methods: Retrospective cohort study of women who delivered singletons at ≥ 34 weeks gestation (2013–2021). Those who had bariatric surgery or infants with major malformations were excluded. Results: Both groups were similar in: primiparity (38%), age (29y), white race (58%), African American (36%), current (10 vs 12%) and former (25 vs 27%) smokers, gestational hypertension (15 vs 16%), polycystic ovary syndrome (5 vs 7%), gastroesophageal reflux disease (10 vs 10%), and anemia (17 vs 17%). Women in the extreme group had a higher prevalence of gestational (17 vs 12%) and pregestational diabetes (12 vs 6%), chronic hypertension (41 vs 17%), severe preeclampsia (18 vs 12%), obstructive sleep apnea (12 vs 3%), asthma (22 vs 16%), and cesarean deliveries (62 vs 44%). Intention to BF (64 vs 71%), exclusive BF (23 vs 34%), and BF initiation (57 vs 64%) rates were lower in the extreme obesity group at discharge. Conclusion: Higher frequency of comorbidities in the extreme obesity group highlights the need for antenatal, intrapartum, and postpartum targeted interventions if the benefits of BF to mothers and infants are to be realized.
- Open Access
- 15 October 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (2) , 101-108
American Society for Metabolic and Bariatric Surgery literature review on risk factors, screening recommendations, and prophylaxis for marginal ulcers after metabolic and bariatric surgery
- 15 October 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (2) , 101-108
Open AccessAmerican Society for Metabolic and Bariatric Surgery literature review on risk factors, screening recommendations, and prophylaxis for marginal ulcers after metabolic and bariatric surgery
- 10 September 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 20 (12) , 1351-1358
The safety profile of one-anastomosis gastric bypass compared to Roux-en-Y gastric bypass: a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program analysis
- 10 September 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 20 (12) , 1351-1358
The safety profile of one-anastomosis gastric bypass compared to Roux-en-Y gastric bypass: a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program analysis
- 11 October 2023
- Published by Elsevier in The American Journal of Surgery
- Vol. 227, 198-203
Gender bias in colorectal surgery fellowship letters of recommendation
- 11 October 2023
- Published by Elsevier in The American Journal of Surgery
- Vol. 227, 198-203
Gender bias in colorectal surgery fellowship letters of recommendation